Next-Generation Autonomous Urine Treatment System

Publication ID: 24-11857716_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Autonomous Urine Treatment System,” Published Technical Disclosure No. 24-11857716_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857716_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,716.

Summary of the Inventive Concept

A futuristic, AI-driven urine treatment system that combines wearable sensors, modular processing units, and decentralized data management to provide personalized, real-time treatment and monitoring.

Background and Problem Solved

The original patent's automatic urine treatment system, while innovative, has limitations in terms of real-time analysis, personalized treatment, and decentralized data management. The new inventive concept addresses these limitations by envisioning a next-generation system that leverages AI, blockchain, and wearable technologies to provide more effective, efficient, and patient-centric care.

Detailed Description of the Inventive Concept

The new inventive concept comprises a wearable, self-cleaning receiver that detects and separates urine from solid waste, and a modular, AI-powered processing unit that analyzes and treats the urine, and communicates with a remote monitoring platform. The system also includes a decentralized network of micro-treatment units, each capable of performing a specific treatment function, and a blockchain-based data management platform that tracks and verifies treatment efficacy and patient outcomes. Additionally, the system features a wearable, implantable device for continuous urine monitoring and treatment, and a virtual reality-based urine treatment simulation platform for personalized guidance and support.

Novelty and Inventive Step

The new inventive concept's use of AI, blockchain, and wearable technologies to provide real-time, personalized, and decentralized urine treatment and monitoring is a significant departure from the original patent's approach. The novel combination of these technologies enables a more efficient, effective, and patient-centric system that addresses the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of sensors, such as optical or electrochemical sensors, or the integration of additional treatment modalities, such as pharmacological or thermal therapies. Variations of the system could also include different types of data management platforms, such as cloud-based or edge computing architectures.

Potential Commercial Applications and Market

The next-generation autonomous urine treatment system has significant commercial potential in the healthcare industry, particularly in the areas of geriatric care, long-term care, and home healthcare. The system's ability to provide real-time, personalized, and decentralized care could also lead to cost savings and improved patient outcomes, making it an attractive solution for healthcare providers and payers.

CPC Classifications

SectionClassGroup
A A61 A61M1/80
A A61 A61F5/441
A A61 A61F5/451
G G01 G01N21/78
G G01 G01N33/493

Field of Art

Medical device technology focused on urine collection, analysis, and treatment systems, with expertise in sensor technologies, medical monitoring, and automated healthcare solutions

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device specialist with advanced degrees, experience in sensor design, medical data processing, and knowledge of assistive technologies for patient care

Obviousness Rationale

A PHOSITA would recognize that the PTD's AI-driven, modular approach represents a predictable technological evolution of the source patent's urine treatment system. The core functional elements of urine collection, analysis, and treatment remain consistent, with the primary innovation being the integration of advanced computational and networking technologies. The PTD's variations represent logical extensions of existing medical device design principles, applying known technologies to improve patient monitoring and treatment processes.

Obvious Combinations & Variations

Source Patent Element
Urine receiver with float sensor and mass sensor for detecting urine levels and characteristics
PTD Variation
Wearable, self-cleaning receiver with AI-powered sensor array and continuous monitoring capabilities
Obviousness Reasoning
A PHOSITA would find it obvious to enhance existing urine detection technologies with advanced sensor arrays, as miniaturization and AI integration are well-established trends in medical device design
Source Patent Element
Urine tank with vacuum pump for transferring negative pressure
PTD Variation
Modular, AI-powered processing unit with decentralized micro-treatment units and robotic assembly capabilities
Obviousness Reasoning
Extending the original system's fluid management concept to a more sophisticated, modular treatment approach represents a predictable application of known medical device design principles
Source Patent Element
Strip with color change units for urine component analysis
PTD Variation
Machine learning algorithm processing data from urine sensor array to generate customized treatment plans
Obviousness Reasoning
Transitioning from static chemical analysis to dynamic, AI-driven diagnostic processing is an obvious technological progression for medical diagnostic systems
Source Patent Element
Urine treatment system with optical sensor units
PTD Variation
Blockchain-based data management platform tracking treatment efficacy and patient outcomes
Obviousness Reasoning
Implementing advanced data tracking and verification technologies is a predictable enhancement to existing medical monitoring systems
Source Patent Element
Automatic urine treatment system for elderly or long-term care patients
PTD Variation
Virtual reality-based treatment simulation platform with AI-driven patient guidance
Obviousness Reasoning
Incorporating advanced patient interaction and training technologies represents a logical extension of existing patient care approaches
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857716 and the disclosed technological variations, a person of ordinary skill in the art would find the claimed innovations obvious and anticipated. The published technical disclosure demonstrates that the claimed advancements represent predictable combinations of known medical device technologies, applying standard design principles to extend the functionality of existing urine treatment systems through computational and networking innovations.

Original Patent Information

Patent NumberUS 11,857,716
TitleAutomatic urine treatment system
Assignee(s)CRADERS Co., Ltd